F L Graham|L Prevec - JoVE Visualize

Showing results (121-130 of 169) with videos related to

Pageof 17

Sort By:

Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997

Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regressionB M Pützer, M Hitt, W J Muller, et al.

Gene Therapy|January 13, 1998

Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alphaR A Marr, C L Addison, D Snider, et al.

Journal of Virology|February 1, 1994

Phosphorylation at the carboxy terminus of the 55-kilodalton adenovirus type 5 E1B protein regulates transforming activityJ G Teodoro, T Halliday, S G Whalen, et al.

Human Gene Therapy|October 20, 1996

Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12J L Bramson, M Hitt, C L Addison, et al.

Human Gene Therapy|November 24, 1999

A high-efficiency Cre/loxP-based system for construction of adenoviral vectorsP Ng, R J Parks, D T Cummings, et al.

Gene Therapy|February 4, 1999

Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumorsC L Addison, J L Bramson, M M Hitt, et al.

Cell|May 20, 1994

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytesI A York, C Roop, D W Andrews, et al.

Human Gene Therapy|November 1, 1995

Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral deliveryP R Clemens, T L Krause, S Chan, et al.

Human Gene Therapy|April 21, 1999

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer modelsP C Emtage, Y Wan, M Hitt, et al.

The Journal of General Virology|February 1, 1990

Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteinsL A Witmer, K L Rosenthal, F L Graham, et al.

Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:

Pageof 17

Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997

Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regressionB M Pützer, M Hitt, W J Muller, et al.

Gene Therapy|January 13, 1998

Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alphaR A Marr, C L Addison, D Snider, et al.

Journal of Virology|February 1, 1994

Phosphorylation at the carboxy terminus of the 55-kilodalton adenovirus type 5 E1B protein regulates transforming activityJ G Teodoro, T Halliday, S G Whalen, et al.

Human Gene Therapy|October 20, 1996

Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12J L Bramson, M Hitt, C L Addison, et al.

Human Gene Therapy|November 24, 1999

A high-efficiency Cre/loxP-based system for construction of adenoviral vectorsP Ng, R J Parks, D T Cummings, et al.

Gene Therapy|February 4, 1999

Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumorsC L Addison, J L Bramson, M M Hitt, et al.

Cell|May 20, 1994

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytesI A York, C Roop, D W Andrews, et al.

Human Gene Therapy|November 1, 1995

Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral deliveryP R Clemens, T L Krause, S Chan, et al.

Human Gene Therapy|April 21, 1999

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer modelsP C Emtage, Y Wan, M Hitt, et al.

The Journal of General Virology|February 1, 1990

Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteinsL A Witmer, K L Rosenthal, F L Graham, et al.

Pageof 17